Pathogen profiling for disease management and surveillance

Nature Reviews Microbiology

Volumn 5, Issue 6, 2007, Pages 464-470

  Sintchenko, Vitali ^a   Iredell, Jonathan R ^a   Gilbert, Gwendolyn L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; DNA FRAGMENT; FENOFOVIR; INDINAVIR; LAMIVUDINE; NEVIRAPINE; PEGINTERFERON; PEGINTERFERON ALPHA; PROTEINASE INHIBITOR; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CAMPYLOBACTER JEJUNI; COMMUNICABLE DISEASE; DISEASE TRANSMISSION; DNA MICROARRAY; EPIDEMIC; ESCHERICHIA COLI; GENOMICS; GENOTYPE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION CONTROL; MEDICAL DECISION MAKING; METABOLOMICS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL GENETICS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEOMICS; PUBLIC HEALTH; SALMONELLA ENTERICA; SEQUENCE ANALYSIS; SEVERE ACUTE RESPIRATORY SYNDROME; TUBERCULOSIS; ZOONOSIS;

BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PHYSIOLOGY; COMPUTATIONAL BIOLOGY; DISEASE MANAGEMENT; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HUMANS; INFECTION CONTROL; VIRAL PHYSIOLOGY; VIRUS DISEASES; VIRUSES;

EID: 34249050849     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1656     Document Type: Article

References (70)

1. Burke, M. D. Laboratory medicine in the 21st century. Am. J. Clin. Pathol. 114, 841-846 (2001).
2. Fey, P. D. & Rupp, M. E. Molecular epidemiology in the public health and hospital environment. Clin. Lab. Med. 23, 885-901 (2003).
3. Matthews, L. & Woolhouse, M. New approaches to quantifying the spread of infection. Nature Rev. Microbiol. 3, 529-536 (2005).
4. Mansmann, U. Genomic profiling: Interplay between clinical epidemiology, bioinformatics and biostatistics. Methods Inf. Med. 44, 454-460 (2005).
5. Sintchenko, V., Iredell, J. & Gilbert, G. L. Culture independent PCR in diagnostic bacteriology: Expectations and reality (is it time to replace the Petri dish with PCR?). Pathology. 31, 436-439 (1999).
6. Kasturi, J. & Acharya, R. Clustering of diverse genomic data using information fusion. Bioinformatics 21, 423-429 (2005).
7. Budowle, B. et al. Genetic analysis and attribution of microbial forensic evidence. Crit. Rev. Microbiol. 31, 233-254 (2005).
8. Campbell, C. J. & Ghazal, P. Molecular signatures for diagnosis of infection: Application of microarray technology. J. Appl. Microbiol. 96, 18-23 (2004).
9. Wilson, W. J. et al. Sequence-specific identification of 18 pathogenic microorganisms using microarray technology. Nucleic Acids Res. 32, 1848-1856 (2004).
10. Konstantinidis, K. & Tiedje, J. M. Genomic insights that advance the species definition for prokaryotes. Proc. Natl Acad. Sci. USA 102, 2567-2572 (2005).
11. Parkhill, J. & Thomson, N. R. in Microbial genomes (eds Fraser, C. M, Read, T. D. & Nelson, K. E.) 269-290 (Humana Press, New Jersey, 2004).
12. Dingle, K. E. et al. Molecular characterization of Campylobacter jejuni clones: A rational basis for epidemiological investigations. Emerg. Infect. Dis. 8, 949-955 (2002).
13. Rotz, L. D. & Hughes, J. M. Advances in detecting and responding to treats from bioterrorism and emerging infectious disease. Nature Med. 10, S130-S136 (2004).
14. Brun-Vezinet, F. et al. Clinically validated genotype analysis: guiding principles and statistical concerns. Antivir. Therapy 9 465-478 (2004).
15. Liu, T. F. & Shafer, R. W. Web resources for HIV type I genotypic-resistance test interpretation. Clin. Infect. Dis. 42 1608-1618 (2006).
16. Hagen, R. M. et al. Development of real-time PCR assay for rapid identification of methicillin-resistant Staphylococcus aureus from clinical samples. Intern. J. Med. Microbiol. 295, 77-86 (2005).
17. Enright, M. C. & Spratt, B. G. Multilocus sequence typing. Trends Microbiol. 7, 482-487 (1999).
18. Urwin, R. & Maiden, M. C. J. Multi-locus sequence typing: A tool for global epidemiology. Trends Microbiol. 11, 479-487 (2003).
19. Blanc, D. S. The use of molecular typing for epidemiological surveillance and investigation of endemic nosocomial infections. Infect. Genet. Evol. 4, 193-197 (2004).
20. Tenover, F. C. et al. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections. Infect. Control Hosp. Epidemiol. 18, 426-439 (1997).
21. Singh, A. et al. Application of molecular techniques to the study of hospital infection. Clin. Microbiol. Rev. 19, 512-530 (2006).
22. Struelens, M. J. Members of the european study group on epidemiological markers. Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems. Clin. Microbiol. Infect. 2, 2-11 (1996).
23. Wartenberg, D. Investigating disease clusters: Why, when and how? J. R. Statist. Soc. A. 164, 13-22 (2001).
24. van Deutekom, H. et al. Molecular typing of Mycobacterium tuberculosis by mycobacterial interspersed repetitive unit-variable number tandem repeat analysis, a more accurate method for identifying epidemiological links between patients with tuberculosis. J. Clin. Microbiol. 43, 4473-4479 (2005).
25. Marchevsky, A. M. & Wick, M. R. Evidence-based medicine, medical decision analysis, and pathology. Hum. Pathol. 35, 1179-1188 (2004).
26. Kuperman, G. J. et al. Improving response to critical laboratory results with automation. J. Am. Med. Inform. Assoc. 6, 512-522 (1999).
27. Lengauer, T. & Sing, T. Bioinformatics-assisted anti-HIV therapy. Nature Rev. Microbiol. 4, 790-797 (2006).
28. Hacek, D. M. et al. Computer-assisted surveillance for detecting clonal outbreaks of nosocomial infection. J. Clin. Microbiol. 42, 1170-1175 (2004).
29. Hacek, D. M. et al. Medical and economic benefit of a comprehensive infection control program that includes routine determination of microbial clonality. Am. J. Clin. Pathol. 111 647-654 (1999).
30. Huang, S. H., Triche, T., Jong, A. Y. Infectomics: Genomics and proteomics of microbial infections. Funct. Integr. Genomic. 1 331-344 (2002).
31. He, Y. et al. PIML: The pathogen information markup language. Bioinformatics 21, 116-121 (2005).
32. McDonald, C. J. et al. LOINC, a universal standard for identifying laboratory observations: A 5-year update. Clin. Chem. 49, 624-633 (2003).
33. Wurtz, R. & Cameron, B. J. Electronic laboratory reporting for the infectious diseases physician and clinical microbiologist. Clin. Infect. Dis. 40, 1638-1643 (2005).
34. Le Novere, N. et al. Minimum information requested in the annotation of biochemical models (MIRIAM). Nature Biotech. 23 1509-1515 (2005).
35. Orchard, S. et al. Common interchange standards for proteomics data: Public availability of tools and schema. Proteomics. 4 490-491 (2004).
36. Louie, B., Mork, P., Martin, F., Halevy, A. & Tarczy-Hornoch, P. Data integration and genomic medicine. J. Biomed. Inform. 40, 5-16 (2007).
37. Grundmann, H., Hori, S. & Tanner, G. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J. Clin. Microbiol. 39, 4190-4192 (2001).
38. Hunter, P. R. & Gaston, M. A. Numerical index of the discriminatory ability of typing systems: An application of Simpson's index of diversity. J. Clin. Microbiol. 26, 2465-2466 (1988).
39. Feil, E. J. & Enright, M. C. Analyses of clonality and the evolution of bacterial pathogens. Curr. Opin. Microbiol. 7, 308-313 (2004).
40. Handl, J., Knowles, J. & Kell, D. B. Computational cluster validation in post-genomic data analysis. Bioinformatics 21, 3201-3212 (2005).
41. Wallinga, J., Edminds, W. J. & Kretzschmar, M. Perspective: Human contact patterns and the spread of airborne infectious diseases. Trends Microbiol. 7, 372-377 (1999).
42. Werner, T. & Nelson, J. Joining high-throughput technology with in silico modelling advances genomewide screening towards targeted discovery. Brief Funct. Genom. Proteom. 5, 32-36 (2006).
43. Marcotte, E. M. et al. Detecting protein function and protein-protein interactions from genome sequences. Science 285 751-753 (1999).
44. Rachman, H. et al. Mycobacterium tuberculosis gene expression profiling within the context of protein networks. Microb. Infect. 8, 747-757 (2006).
45. Maiden, M. C. Multilocus sequence typing of bacteria. Annu. Rev. Microbiol. 60, 561-588 (2006).
46. Lisacek, F., Cohen-Boulakia, S. & Appel, R. D. Proteome bioinformatics II. Bioinformatics for comparative proteomics. Proteomics 6, 5445-5466 (2006).
47. Achard, F., Vaysseix, G. & Barillot, E. XML, bioinformatics and data integration. Bioinformatics 17, 115-125 (2001).
48. Pelegrini, M. et al. Assigning protein functions by comparative genome analysis: Protein phylogenetic profiles. Proc. Natl Acad. Sci. USA 96, 4285-4288 (1999).
49. Xu, J. Microbial ecology in the age of genomics and metagenomics: concepts, tools, and recent advances. Mol. Ecol. 15, 1713-1731 (2006).
50. Saminathan, B. et al. PulseNet: The molecular subtyping network for foodborne bacterial disease surveillance, United States. Emerg. Infect. Dis. 7, 382-389 (2001).
51. Donofrio, N. M. et al. PACLIMS: A component LIM system for high throughput functional genomic analysis. BMC Bioinformatics 6 94 (2005).
52. Zhao, L-J., Li, M-X., Guo, Y-F., Xu, F-H. & Li, J-L., Deng, H-W. SNPP: automating large scale SNP genotype data management. Bioinformatics 21, 266-268 (2005).
53. Birkholtz, L-M. et al. Integration and mining of malaria molecular, functional and pharmacological data: How far are we from a chemogenomic knowledge space? Malaria J. 5, 110 (2006).
54. Rappuoli, R. Reverse vaccinology. Curr. Opin. Microbiol. 3, 445-450 (2000).
55. Boguski, M. S. & McIntosh, M. W. Biomedical informatics for proteomics. Nature 422, 233-237 (2003).
56. DeGruttola, V. et al. The relation between baseline HIV drug resistance and response to antiretroviral therapy: Re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir. Ther. 5, 41-48 (2000).
57. De Luca, A. et al. Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance. J. Infect. Dis. 187, 1934-1943 (2003).
58. Lloyd-Smith, J. O. et al. Superspreading and the effect of individual variation on disease emergence. Nature 438, 355-359 (2005).
59. Malik, A. N. J. Godfrey-Faussett, P. Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease. Lancet Infect. Dis. 5, 174-183 (2005).
60. Sintchenko, V. & Gilbert, G. L. Utility of genotyping of Mycobacterium tuberculosis in the contact investigation: A decision analysis. Tuberculosis 87, 176-184 (2007).
61. Gardner, S. P. Ontologies and semantic data integration. Drug Disc. Today:BIosilico 10, 1001-1007 (2005).
62. Ecker, D. J. et al. Rapid identification and strain-typing of respiratory pathogens for epidemic surveillance. Proc. Natl Acad. Sci. USA 102, 8012-8017 (2005).
63. Mellmann, A. et al. Automated DNA sequence-based early warning system for the detection of methicillin-resistant Staphylococcus aureus outbreaks. PloS Medicine. 3, e3 (2006).
64. Gierl, L. & Schmidt, R. Geomedical warning system against epidemic. Int. J. Hyg. Environ. Health 208, 287-297 (2005).
65. King, H. C. & Sinha, A. A. Gene expression profile analysis by DNA microarrays: Promise and pitfalls. J. Am. Med. Assoc. 286, 2280-2288 (2001).
66. Geretti, A. HIV-1 subtypes: Epidemiology and significance for HIV management. Curr. Opin. Infect. Dis. 19, 1-7 (2006).
67. Berman, J. J. Pathology data integration with eXtensible Markup Language. Hum. Pathol. 36, 139-145 (2005).
68. Pawlotsky, J-M. Therapy of hepatitis C: From empiricism to eradication. Hepatol. 43, S207-S220 (2006).
69. Scott, J. D. & Gretch, D. R. Molecular diagnostics of hepatitis C virus infection: A systematic review. J. Am. Med. Assoc. 297, 724-732 (2007).
70. Wohnsland, A., Hofmann, W. P. & Sarrazin, C. Viral determinants of resistance to treatment in patients with hepatitis C. Clin. Microbiol. Rev. 20, 23-38 (2007).